Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients
Early treatment optimization improves clinical outcomes and reduces morbidity and mortality in patients with acute myocardial infarction (AMI). Intravenous beta-adrenoblocker (BAB) therapy, associated with improved survival, is well tolerated by AMI patients. The results of relevant clinical trials...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1497 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849342118867238912 |
|---|---|
| author | S. N. Tereshchenko I. V. Zhirov |
| author_facet | S. N. Tereshchenko I. V. Zhirov |
| author_sort | S. N. Tereshchenko |
| collection | DOAJ |
| description | Early treatment optimization improves clinical outcomes and reduces morbidity and mortality in patients with acute myocardial infarction (AMI). Intravenous beta-adrenoblocker (BAB) therapy, associated with improved survival, is well tolerated by AMI patients. The results of relevant clinical trials are presented. The causes of possible increase in cardiogenic shock risk for metoprolol group, COMMIT trial, are analyzed. Evidence base for early BAB therapy in AMI patients is presented. |
| format | Article |
| id | doaj-art-0d6a235be87f4c8eb42da1a60dde50ac |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 1970-01-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-0d6a235be87f4c8eb42da1a60dde50ac2025-08-20T03:43:29Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-017790941215Intravenous beta-adrenoblocker therapy in acute coronary syndrome patientsS. N. Tereshchenko0I. V. Zhirov1Moscow State Medico-Stomatological University, State Federal Agency for Health and Social Development, MoscowMoscow State Medico-Stomatological University, State Federal Agency for Health and Social Development, MoscowEarly treatment optimization improves clinical outcomes and reduces morbidity and mortality in patients with acute myocardial infarction (AMI). Intravenous beta-adrenoblocker (BAB) therapy, associated with improved survival, is well tolerated by AMI patients. The results of relevant clinical trials are presented. The causes of possible increase in cardiogenic shock risk for metoprolol group, COMMIT trial, are analyzed. Evidence base for early BAB therapy in AMI patients is presented.https://cardiovascular.elpub.ru/jour/article/view/1497acute myocardial infarctionbeta-adrenoblockerscardiogenic shockgenetic polymorphism |
| spellingShingle | S. N. Tereshchenko I. V. Zhirov Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients Кардиоваскулярная терапия и профилактика acute myocardial infarction beta-adrenoblockers cardiogenic shock genetic polymorphism |
| title | Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients |
| title_full | Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients |
| title_fullStr | Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients |
| title_full_unstemmed | Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients |
| title_short | Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients |
| title_sort | intravenous beta adrenoblocker therapy in acute coronary syndrome patients |
| topic | acute myocardial infarction beta-adrenoblockers cardiogenic shock genetic polymorphism |
| url | https://cardiovascular.elpub.ru/jour/article/view/1497 |
| work_keys_str_mv | AT sntereshchenko intravenousbetaadrenoblockertherapyinacutecoronarysyndromepatients AT ivzhirov intravenousbetaadrenoblockertherapyinacutecoronarysyndromepatients |